http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 08 Jul 2026 08:07:59 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+PT+Change/BioNTech+%28BNTX%29+PT+Lowered+to+%24119+at+Morgan+Stanley/26744654.html Morgan Stanley analyst Terence Flynn lowered the price target on BioNTech (NASDAQ: BNTX) to $119.00 (from $126.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/BioNTech+%28BNTX%29+PT+Lowered+to+%24119+at+Morgan+Stanley/26744654.html Wed, 08 Jul 2026 08:07:59 -0400 BNTX http://www.streetinsider.com/SEC+Filings/Form++3++++++++++BioNTech+SE+++++++++++++++For%3A+Jun+26++Filed+by%3A+Low-Friedrich+Iris+Katharina/26695593.html si-local-file:///var/storage/secattach/20260626/26695593.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++BioNTech+SE+++++++++++++++For%3A+Jun+26++Filed+by%3A+Low-Friedrich+Iris+Katharina/26695593.html Fri, 26 Jun 2026 09:11:00 -0400 0A3M BNTX O.07073414 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++BioNTech+SE+++++++++++++++For%3A+Jun+26++Filed+by%3A+Low-Friedrich+Iris+Katharina/26695593.html si-local-file:///var/storage/secattach/20260626/26695593.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++BioNTech+SE+++++++++++++++For%3A+Jun+26++Filed+by%3A+Low-Friedrich+Iris+Katharina/26695593.html Fri, 26 Jun 2026 09:11:00 -0400 0A3M BNTX O.07073414 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++BioNTech+SE+++++++++++++++For%3A+Jun+26++Filed+by%3A+Low-Friedrich+Iris+Katharina/26695593.html si-local-file:///var/storage/secattach/20260626/26695593.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++BioNTech+SE+++++++++++++++For%3A+Jun+26++Filed+by%3A+Low-Friedrich+Iris+Katharina/26695593.html Fri, 26 Jun 2026 09:11:00 -0400 0A3M BNTX O.07073414 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++BioNTech+SE+++++++++++++++For%3A+Jun+26++Filed+by%3A+Schaffert+Susanne/26695583.html si-local-file:///var/storage/secattach/20260626/26695583.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++BioNTech+SE+++++++++++++++For%3A+Jun+26++Filed+by%3A+Schaffert+Susanne/26695583.html Fri, 26 Jun 2026 09:09:00 -0400 0A3M BNTX O.07073414 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++BioNTech+SE+++++++++++++++For%3A+Jun+26++Filed+by%3A+Schaffert+Susanne/26695583.html si-local-file:///var/storage/secattach/20260626/26695583.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++BioNTech+SE+++++++++++++++For%3A+Jun+26++Filed+by%3A+Schaffert+Susanne/26695583.html Fri, 26 Jun 2026 09:09:00 -0400 0A3M BNTX O.07073414 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++BioNTech+SE+++++++++++++++For%3A+Jun+26++Filed+by%3A+Schaffert+Susanne/26695583.html si-local-file:///var/storage/secattach/20260626/26695583.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++BioNTech+SE+++++++++++++++For%3A+Jun+26++Filed+by%3A+Schaffert+Susanne/26695583.html Fri, 26 Jun 2026 09:09:00 -0400 0A3M BNTX O.07073414 http://www.streetinsider.com/Press+Releases/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html <p>DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=7BgHDQzGfLx-veeYYMh_0eRTtl803PJ2sqFIVEev7Qcfb8-b0GntM5UFwFQviWtGeHdFOst8HFNoZAnOvrg4lBFnfhm8ovQ0BJao_Gi4G4M=" rel="nofollow" target="_blank">247marketnews.com</a>) – Cancer treatment is undergoing one of the most significant transformations in modern medical history.</p> <p>For decades, physicians relied primarily on surgery, radiation, and chemotherapy. While those therapies have saved countless lives, a new generation of biotechnology companies is working to make cancer treatment smarter, more targeted, and potentially more effective.</p> <p>Rather than simply attacking rapidly dividing cells, researchers are developing therapies designed to identify specific genetic mutations, harness the immune system, and deliver treatments directly to cancer cells while minimizing damage to healthy tissue.</p> http://www.streetinsider.com/Press+Releases/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html Thu, 25 Jun 2026 11:39:11 -0400 BNTX CGON NTHI SMMT http://www.streetinsider.com/Press+Releases/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html <p>DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=7BgHDQzGfLx-veeYYMh_0eRTtl803PJ2sqFIVEev7Qcfb8-b0GntM5UFwFQviWtGeHdFOst8HFNoZAnOvrg4lBFnfhm8ovQ0BJao_Gi4G4M=" rel="nofollow" target="_blank">247marketnews.com</a>) – Cancer treatment is undergoing one of the most significant transformations in modern medical history.</p> <p>For decades, physicians relied primarily on surgery, radiation, and chemotherapy. While those therapies have saved countless lives, a new generation of biotechnology companies is working to make cancer treatment smarter, more targeted, and potentially more effective.</p> <p>Rather than simply attacking rapidly dividing cells, researchers are developing therapies designed to identify specific genetic mutations, harness the immune system, and deliver treatments directly to cancer cells while minimizing damage to healthy tissue.</p> http://www.streetinsider.com/Press+Releases/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html Thu, 25 Jun 2026 11:39:11 -0400 BNTX CGON NTHI SMMT http://www.streetinsider.com/Press+Releases/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html <p>DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=7BgHDQzGfLx-veeYYMh_0eRTtl803PJ2sqFIVEev7Qcfb8-b0GntM5UFwFQviWtGeHdFOst8HFNoZAnOvrg4lBFnfhm8ovQ0BJao_Gi4G4M=" rel="nofollow" target="_blank">247marketnews.com</a>) – Cancer treatment is undergoing one of the most significant transformations in modern medical history.</p> <p>For decades, physicians relied primarily on surgery, radiation, and chemotherapy. While those therapies have saved countless lives, a new generation of biotechnology companies is working to make cancer treatment smarter, more targeted, and potentially more effective.</p> <p>Rather than simply attacking rapidly dividing cells, researchers are developing therapies designed to identify specific genetic mutations, harness the immune system, and deliver treatments directly to cancer cells while minimizing damage to healthy tissue.</p> http://www.streetinsider.com/Press+Releases/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html Thu, 25 Jun 2026 11:39:11 -0400 BNTX CGON NTHI SMMT http://www.streetinsider.com/Press+Releases/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html <p>DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=7BgHDQzGfLx-veeYYMh_0eRTtl803PJ2sqFIVEev7Qcfb8-b0GntM5UFwFQviWtGeHdFOst8HFNoZAnOvrg4lBFnfhm8ovQ0BJao_Gi4G4M=" rel="nofollow" target="_blank">247marketnews.com</a>) – Cancer treatment is undergoing one of the most significant transformations in modern medical history.</p> <p>For decades, physicians relied primarily on surgery, radiation, and chemotherapy. While those therapies have saved countless lives, a new generation of biotechnology companies is working to make cancer treatment smarter, more targeted, and potentially more effective.</p> <p>Rather than simply attacking rapidly dividing cells, researchers are developing therapies designed to identify specific genetic mutations, harness the immune system, and deliver treatments directly to cancer cells while minimizing damage to healthy tissue.</p> http://www.streetinsider.com/Press+Releases/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html Thu, 25 Jun 2026 11:39:11 -0400 BNTX CGON NTHI SMMT http://www.streetinsider.com/Globe+Newswire/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html <p>DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=7BgHDQzGfLx-veeYYMh_0eRTtl803PJ2sqFIVEev7Qcfb8-b0GntM5UFwFQviWtGeHdFOst8HFNoZAnOvrg4lBFnfhm8ovQ0BJao_Gi4G4M=" rel="nofollow" target="_blank">247marketnews.com</a>) – Cancer treatment is undergoing one of the most significant transformations in modern medical history.</p> <p>For decades, physicians relied primarily on surgery, radiation, and chemotherapy. While those therapies have saved countless lives, a new generation of biotechnology companies is working to make cancer treatment smarter, more targeted, and potentially more effective.</p> <p>Rather than simply attacking rapidly dividing cells, researchers are developing therapies designed to identify specific genetic mutations, harness the immune system, and deliver treatments directly to cancer cells while minimizing damage to healthy tissue.</p> http://www.streetinsider.com/Globe+Newswire/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html Thu, 25 Jun 2026 11:39:11 -0400 BNTX CGON NTHI SMMT http://www.streetinsider.com/Globe+Newswire/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html <p>DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=7BgHDQzGfLx-veeYYMh_0eRTtl803PJ2sqFIVEev7Qcfb8-b0GntM5UFwFQviWtGeHdFOst8HFNoZAnOvrg4lBFnfhm8ovQ0BJao_Gi4G4M=" rel="nofollow" target="_blank">247marketnews.com</a>) – Cancer treatment is undergoing one of the most significant transformations in modern medical history.</p> <p>For decades, physicians relied primarily on surgery, radiation, and chemotherapy. While those therapies have saved countless lives, a new generation of biotechnology companies is working to make cancer treatment smarter, more targeted, and potentially more effective.</p> <p>Rather than simply attacking rapidly dividing cells, researchers are developing therapies designed to identify specific genetic mutations, harness the immune system, and deliver treatments directly to cancer cells while minimizing damage to healthy tissue.</p> http://www.streetinsider.com/Globe+Newswire/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html Thu, 25 Jun 2026 11:39:11 -0400 BNTX CGON NTHI SMMT http://www.streetinsider.com/Globe+Newswire/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html <p>DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=7BgHDQzGfLx-veeYYMh_0eRTtl803PJ2sqFIVEev7Qcfb8-b0GntM5UFwFQviWtGeHdFOst8HFNoZAnOvrg4lBFnfhm8ovQ0BJao_Gi4G4M=" rel="nofollow" target="_blank">247marketnews.com</a>) – Cancer treatment is undergoing one of the most significant transformations in modern medical history.</p> <p>For decades, physicians relied primarily on surgery, radiation, and chemotherapy. While those therapies have saved countless lives, a new generation of biotechnology companies is working to make cancer treatment smarter, more targeted, and potentially more effective.</p> <p>Rather than simply attacking rapidly dividing cells, researchers are developing therapies designed to identify specific genetic mutations, harness the immune system, and deliver treatments directly to cancer cells while minimizing damage to healthy tissue.</p> http://www.streetinsider.com/Globe+Newswire/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html Thu, 25 Jun 2026 11:39:11 -0400 BNTX CGON NTHI SMMT http://www.streetinsider.com/Globe+Newswire/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html <p>DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=7BgHDQzGfLx-veeYYMh_0eRTtl803PJ2sqFIVEev7Qcfb8-b0GntM5UFwFQviWtGeHdFOst8HFNoZAnOvrg4lBFnfhm8ovQ0BJao_Gi4G4M=" rel="nofollow" target="_blank">247marketnews.com</a>) – Cancer treatment is undergoing one of the most significant transformations in modern medical history.</p> <p>For decades, physicians relied primarily on surgery, radiation, and chemotherapy. While those therapies have saved countless lives, a new generation of biotechnology companies is working to make cancer treatment smarter, more targeted, and potentially more effective.</p> <p>Rather than simply attacking rapidly dividing cells, researchers are developing therapies designed to identify specific genetic mutations, harness the immune system, and deliver treatments directly to cancer cells while minimizing damage to healthy tissue.</p> http://www.streetinsider.com/Globe+Newswire/The+New+War+on+Cancer%3A+Four+Public+Companies+Helping+Lead+a+Medical+Revolution/26690254.html Thu, 25 Jun 2026 11:39:11 -0400 BNTX CGON NTHI SMMT http://www.streetinsider.com/Trader+Talk/German+government+to+drop+variable+drug+discounting+plans+-+Reuters/26643609.html <p>German government to drop variable drug discounting plans - Reuters</p> http://www.streetinsider.com/Trader+Talk/German+government+to+drop+variable+drug+discounting+plans+-+Reuters/26643609.html Mon, 15 Jun 2026 06:08:37 -0400 BNTX GSK MRK NVS PFE http://www.streetinsider.com/Trader+Talk/German+government+to+drop+variable+drug+discounting+plans+-+Reuters/26643609.html <p>German government to drop variable drug discounting plans - Reuters</p> http://www.streetinsider.com/Trader+Talk/German+government+to+drop+variable+drug+discounting+plans+-+Reuters/26643609.html Mon, 15 Jun 2026 06:08:37 -0400 BNTX GSK MRK NVS PFE http://www.streetinsider.com/Trader+Talk/German+government+to+drop+variable+drug+discounting+plans+-+Reuters/26643609.html <p>German government to drop variable drug discounting plans - Reuters</p> http://www.streetinsider.com/Trader+Talk/German+government+to+drop+variable+drug+discounting+plans+-+Reuters/26643609.html Mon, 15 Jun 2026 06:08:37 -0400 BNTX GSK MRK NVS PFE http://www.streetinsider.com/Trader+Talk/German+government+to+drop+variable+drug+discounting+plans+-+Reuters/26643609.html <p>German government to drop variable drug discounting plans - Reuters</p> http://www.streetinsider.com/Trader+Talk/German+government+to+drop+variable+drug+discounting+plans+-+Reuters/26643609.html Mon, 15 Jun 2026 06:08:37 -0400 BNTX GSK MRK NVS PFE http://www.streetinsider.com/Trader+Talk/German+government+to+drop+variable+drug+discounting+plans+-+Reuters/26643609.html <p>German government to drop variable drug discounting plans - Reuters</p> http://www.streetinsider.com/Trader+Talk/German+government+to+drop+variable+drug+discounting+plans+-+Reuters/26643609.html Mon, 15 Jun 2026 06:08:37 -0400 BNTX GSK MRK NVS PFE http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++BioNTech+SE+++++++++++++++For%3A+Jun+08/26614584.html si-local-file:///var/storage/secattach/20260608/26614584.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++BioNTech+SE+++++++++++++++For%3A+Jun+08/26614584.html Mon, 08 Jun 2026 08:01:00 -0400 0A3M BNTX O.07073414 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++BioNTech+SE+++++++++++++++For%3A+Jun+08/26614584.html si-local-file:///var/storage/secattach/20260608/26614584.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++BioNTech+SE+++++++++++++++For%3A+Jun+08/26614584.html Mon, 08 Jun 2026 08:01:00 -0400 0A3M BNTX O.07073414 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++BioNTech+SE+++++++++++++++For%3A+Jun+08/26614584.html si-local-file:///var/storage/secattach/20260608/26614584.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++BioNTech+SE+++++++++++++++For%3A+Jun+08/26614584.html Mon, 08 Jun 2026 08:01:00 -0400 0A3M BNTX O.07073414 http://www.streetinsider.com/Analyst+Comments/Bernstein+SocGen+Group+Reiterates+Market+Perform+Rating+on+BioNTech+%28BNTX%29/26608863.html <p>Bernstein SocGen Group analyst Jeffrey Walch reiterated a Market Perform rating and $96.00 price target on BioNTech (NASDAQ: BNTX).</p><p>The analyst commented: "Post-ASCO, pumitamig has the same downside risk as ivonescimab; We sharpen our answer for BNTX post-ASCO. However, we land on the same recommendation: investors should pass on BNTX at this time because of their aggressive pumitamig (PD-L1/VEGF) clinical development plan. We still see a high risk of negative registrational trials for the drug class (along with SMMT’s ivonescimab) due to historical failure to achieve a statistically significant survival benefit. We maintain our perspective that the consensus view of probability http://www.streetinsider.com/Analyst+Comments/Bernstein+SocGen+Group+Reiterates+Market+Perform+Rating+on+BioNTech+%28BNTX%29/26608863.html Fri, 05 Jun 2026 09:00:54 -0400 BNTX http://www.streetinsider.com/Investing/Lilly+cuts+Germany+investment+plan+in+half+over+healthcare+reforms/26597912.html <p>Investing.com -- Eli Lilly and Company announced Wednesday it will reduce its remaining investment in a German production facility by half, cutting $1.5 billion from its spending plans and eliminating a substantial portion of 1,000 planned jobs.</p><p>The Indianapolis-based pharmaceutical company cited proposed healthcare reforms in Germany that aim to lower drug prices as the reason for scaling back the $2.5 billion project in Alzey. Interior work at the site continues and 300 employees have been hired, ensuring the facility will become operational.</p><p>Lilly said the decision to expand remaining capacity has been suspended and will depend on whether stable and predictable http://www.streetinsider.com/Investing/Lilly+cuts+Germany+investment+plan+in+half+over+healthcare+reforms/26597912.html Wed, 03 Jun 2026 13:17:16 -0400 BNTX LLY